55
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Metabolism of Haloperidol and Its Tetrahydropyridine Dehydration Product HPTP

, &
Pages 809-826 | Published online: 22 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Shufeng Zhou, Eli Chan, Wei Duan, Min Huang & Yu-Zong Chen. (2005) Drug Bioactivation Covalent Binding to Target Proteins and Toxicity Relevance. Drug Metabolism Reviews 37:1, pages 41-213.
Read now
Slobodan Rendic. (2002) Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metabolism Reviews 34:1-2, pages 83-448.
Read now
Etsuko Usuki, JeffreyR. Bloomquist, Ethan Freeborn, Kay Castagnoli, CornelisJ. Van der Schyf & Neal Castagnoli$suffix/text()$suffix/text(). (2002) Metabolic Studies on Haloperidol and Its Tetrahydropyridinyl Dehydration Product (HPTP) in C57BL/6 Mouse Brain Preparations. Neurotoxicity Research 4:1, pages 51-58.
Read now

Articles from other publishers (11)

Nicholas A. Meanwell & Olivier Loiseleur. (2022) Applications of Isosteres of Piperazine in the Design of Biologically Active Compounds: Part 1. Journal of Agricultural and Food Chemistry 70:36, pages 10942-10971.
Crossref
Francesca Serena Abatematteo, Mauro Niso, Marialessandra Contino, Marcello Leopoldo & Carmen Abate. (2021) Multi-Target Directed Ligands (MTDLs) Binding the σ1 Receptor as Promising Therapeutics: State of the Art and Perspectives. International Journal of Molecular Sciences 22:12, pages 6359.
Crossref
Slobodan P. Rendic & F. Peter Guengerich. (2021) Human Family 1–4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update. Archives of Toxicology 95:2, pages 395-472.
Crossref
Ji-Young ParkJae-Gook Shin. (2016) Development and validation of a HPLC-UV method for 4-(4-chlorophenyl)-4-hydroxypiperidine (CPHP), a toxic metabolite of haloperidol, in humans: providing in vivo evidence of CYP3A4-mediated CPHP formation. Translational and Clinical Pharmacology 24:3, pages 147.
Crossref
Donald J. AbrahamJulian Blagg. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery 301 334 .
Carl D. Davis & Umesh M. Hanumegowda. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia 1 68 .
Carl D. Davis & Umesh M. Hanumegowda. 2009. Drug Metabolism Handbook. Drug Metabolism Handbook 559 628 .
Masakazu Hanagama, Hiromasa Inoue, Munechika Kamiya, Kotaro Shinone & Masayuki Nata. (2008) Gene expression on liver toxicity induced by administration of haloperidol in rats with severe fatty liver. Legal Medicine 10:4, pages 177-184.
Crossref
Makoto Kawai, Hiroshi Nakamura, Isao Sakurada, Hirohisa Shimokawa, Hirotaka Tanaka, Miyako Matsumizu, Kazuo Ando, Kazunari Hattori, Atsuko Ohta, Seiji Nukui, Atsushi Omura & Mitsuhiro Kawamura. (2007) Discovery of novel and orally active NR2B-selective N-methyl-d-aspartate (NMDA) antagonists, pyridinol derivatives with reduced HERG binding affinity. Bioorganic & Medicinal Chemistry Letters 17:20, pages 5533-5536.
Crossref
Enrique J. Cobos, Esperanza del Pozo & José M. Baeyens. (2007) Irreversible blockade of sigma-1 receptors by haloperidol and its metabolites in guinea pig brain and SH-SY5Y human neuroblastoma cells. Journal of Neurochemistry 102:3, pages 812-825.
Crossref
Lodewyk J. Mienie, Jacobus J. Bergh, Jeffrey R. Bloomquist, Neal CastagnoliJr.Jr., Stefanus J. Steyn & Cornelis J. Van der Schyf. (1999) p-Fluorophenylglycine in the urine of baboons treated with HPTP, the tetrahydropyridine analog of haloperidol. Life Sciences 65:5, pages 535-542.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.